Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-19

Clinical Trial Update: A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults [NA]

View source ↗

Summary

A pilot study investigated the efficacy and safety of topical oxybutynin 3% gel for primary focal hyperhidrosis in adolescents and young adults; the trial has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin topical gel 3% (oxybutynin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Hyperhidrosis | NA | Status: COMPLETED | Results posted: 2018-06-19